Mental Health Care Provider's Perspectives Toward Adopting a Novel Technology to Improve Medication Adherence.

Objective: To understand perspectives of mental health care providers regarding barriers and drivers of adopting a medication ingestible event monitoring (IEM) system in clinical practice.

Methods: Between April and October 2019, a cross-sectional, online survey was conducted among 131 prescribing clinicians and 119 non-prescribing clinicians providing care to patients with major depressive disorder, bipolar disorder, and schizophrenia.

Results: Most prescribing clinicians were physicians (79.

Prescriber Attitudes, Experiences, and Proclivities Toward Digital Medicine and How They Influence Adoption of Digital Medicine Platforms.

Background: Psychiatric prescribers (prescribers) typically assess medication adherence by patient or caregiver self-report. Despite likely clinical benefit of a new digital medicine technology, the role of specific prescriber attitudes, behaviors, and experiences in the likelihood of adoption is unclear.

Objective: To identify prescriber characteristics that may affect adoption of the ingestible event marker (IEM) platform.

Risk of Chronic Kidney Disease in Brushite Stone Formers Compared With Idiopathic Calcium Oxalate Stone Formers.

Objective: To study brushite stone formers (BSFs) change in renal function and overall risk of progression to chronic kidney disease (CKD) over time.

Materials And Methods: A retrospective review of all patients with urolithiasis on stone analysis was performed from 1995 to 2003. Stones were classified as brushite if they had at least 10% brushite composition on analysis.